Citigroup’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Citigroup’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-133	Closed	–	–	8282
2015 Q3	$0	Buy	+133	New	+$148	﹤0.01%	8281
2015 Q2	–	Sell	-4	Closed	–	–	8110
2015 Q1	$0	Buy	+4	New	+$16	﹤0.01%	7715
2014 Q3	–	Sell	-8	Closed	–	–	7543
2014 Q2	$0	Buy	+8	New	+$139	﹤0.01%	7545

Other funds holding RCPI

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

KCM

Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

WealthPLAN Partners Omaha, Nebraska $518M AUM 17.96% 1-Year Est. Return

IWMPD

Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 12.85% 1-Year Est. Return

Citigroup's RCPI Position: Q4 2015 in Review

Citigroup sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 133 shares.

Citigroup first reported a position in RCPI in Q2 2014 and held it in 3 quarters. The position peaked at $0 in Q3 2015. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

Citigroup reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
Citigroup sold 133 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015.
Citigroup first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 3 quarters.
Citigroup's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $0 in Q3 2015.
9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Citigroup's 13F filing for Q4 2015, filed 12 Feb 2016.